FDA approves first RSV vaccine

[Fox 9 News, May 03, 2023] The Food and Drug Administration has approved the world's first respiratory syncytial virus (RSV) vaccine, a shot for adults ages 60 and up. The vaccine still needs CDC approval. RSV infects nearly everyone by age 2 and typically causes cold symptoms. It is the leading cause of hospitalizations among newborns and younger children. But, RSV also strikes late in life, causing more than 177,000 hospitalizations and 14,000 deaths among older adults each year. Allina Health infectious disease specialist Frank Rhame, MD, talked with Fox 9 News about the significance of this development.

Posted on May 04, 2023 in Infectious Disease

Share this article